News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3127last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
MT Newswires46d agoneutral
Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver AilmentsMotley Fool47d agoneutral
Novo Nordisk Has a Fresh New Name -- but It Still Faces the Same Old ProblemsStocktwits47d agobullish
VKTX Stock Jumps 36% As Oppenheimer Hikes Target, Peers Call Data A WinBarrons.com47d agoneutral
Beyond Eli Lilly and Novo Nordisk: Rising Obesity Drug Stocks to Watch24/7 Wall St.47d agobullish
Viking Soars Alone as Obesity Complex Shrugs at Strong GLP-1 ResultsMT Newswires47d agoneutral
European Markets Close Mixed Ahead of Trump-Xi Summit; Saudi Arabia Oil Pipeline RestartsThe Wall Street Journal47d agoneutral
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in TrialBarrons.com47d agobullish
Viking Therapeutics Stock Surges 30%. It Could Challenge Lilly and Novo’s Obesity Empire.InvestorsHub47d agoneutral
Roche Obesity Drug Enicepatide Delivers 15.5% Weight Loss in Phase 2 Diabetes TrialInvestor's Business Daily47d agobearish
Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.Stocktwits47d agobullish
VKTX Stock Spikes 38% Premarket: Viking’s VK2735 Shows Promise For Weight-Loss Maintenance24/7 Wall St.47d agoneutral
Eli Lilly’s Tough Month: One of The Biggest Global Banks Says 37% Gains Begin SoonInvestorsHub47d agoneutral
Novo Nordisk Considers Acquisitions to Expand Weight-Loss Drug Pipeline as Competition IntensifiesInsider Monkey48d agoneutral
Novo Nordisk Partners with Anthropic to Bring AI Deeper into Drug Discovery